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Background: Interstitial fibrosis is an early and consistent pathologic feature in hypertrophic cardiomyopathy (HCM). T1 mapping by magnetic 
resonance (CMR) is thought to be an imaging biomarker for interstitial fibrosis and has been shown to be abnormal in HCM gene positive persons 
even in the absence of hypertrophy (LVH). However, it is not known if T1 times reflect disease severity in established HCM.
Methods: Clinical examination, echocardiography and CMR were performed in 259 HCM patients across a wide spectrum of disease (59 non 
obstructive, 59 obstructive, 102 labile obstructive, 39 unavailable; 69.5% men). T1 values were calculated from a post-gadolinium Look-Locker (LL) 
inversion recovery sequence. T1 relaxation time was calculated using Mass research software (version V2012-EXP, Leiden University Medical Center, 
Leiden, Netherlands). Late gadolinium enhancement (LGE) was quantified using a semiautomated technique that defined LGE as signal intensity (SI) 
6SD greater than the mean SI of normal myocardium.
results: Mean T1 times were 385.5 ± 60.8 msec. Linear regression showed significant negative correlation between T1 times and % LGE (r = 
-0.200, p = 0.001). There was no correlation between T1 times and LV mass by CMR (r = 0.112; p=0.071), max LV wall thickness(r = -0.006; 
p=0.929) and E/e’ ratio (r = 0.018; p=0.809). One-way ANOVA showed no significant difference in T1 times among diastolic function grades (p 
= 0.207). We used clinical and imaging criteria to separate HCM into mild and severe groups using the following criteria - LV wall <2 cm; non 
restrictive DD grade; E/e’<15; <15% LGE. Mean T1 times were not statistically different between the two groups: LV wall thickness (384.1 ± 57.4 vs. 
391.0 ± 66.6), DD grade (390.8 ± 61.4 vs. 402.9 ± 56.0), E/e’ (391.3 ± 65.8 vs. 397.7 ± 56.8) and % LGE (390.3 ± 60.2 vs. 373.04 ± 61.0).
conclusions: Although T1 times may be a marker for early fibrosis in HCM, they do not correlate with other imaging based phenotypic markers of 
HCM in established disease. Our data suggest that T1 mapping may be best implemented for detection of early HCM rather than to monitor HCM 
progression in later stages.
